Media headlines about Omega Healthcare Investors (NYSE:OHI) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Omega Healthcare Investors earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the real estate investment trust an impact score of 46.3703898453163 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Shares of Omega Healthcare Investors (NYSE:OHI) traded up $0.47 during midday trading on Tuesday, hitting $28.64. The stock had a trading volume of 1,497,371 shares, compared to its average volume of 2,094,489. Omega Healthcare Investors has a twelve month low of $27.32 and a twelve month high of $35.14. The stock has a market capitalization of $5,630.00, a price-to-earnings ratio of 8.25, a price-to-earnings-growth ratio of 2.92 and a beta of 0.53. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.40 and a current ratio of 3.40.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Tuesday, October 31st will be issued a $0.65 dividend. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.64. This represents a $2.60 annualized dividend and a yield of 9.08%. The ex-dividend date is Monday, October 30th. Omega Healthcare Investors’s payout ratio is currently 333.33%.
A number of research analysts have commented on the company. Zacks Investment Research cut Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Friday, November 3rd. SunTrust Banks, Inc. reaffirmed a “hold” rating and set a $30.00 target price on shares of Omega Healthcare Investors in a research report on Wednesday, November 1st. Hilliard Lyons lowered Omega Healthcare Investors to a “buy” rating in a research report on Wednesday, November 1st. TheStreet lowered Omega Healthcare Investors from a “b-” rating to a “c” rating in a research report on Monday, October 30th. Finally, Stifel Nicolaus lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and dropped their target price for the stock from $35.00 to $29.00 in a research report on Tuesday, October 31st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $31.83.
ILLEGAL ACTIVITY WARNING: “Omega Healthcare Investors (OHI) Getting Somewhat Favorable Press Coverage, Analysis Finds” was originally published by Stock Observer and is the sole property of of Stock Observer. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.thestockobserver.com/2017/11/14/omega-healthcare-investors-ohi-getting-somewhat-favorable-press-coverage-analysis-finds.html.
In other news, Director Craig R. Callen acquired 10,000 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was purchased at an average cost of $27.38 per share, with a total value of $273,800.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bernard J. Korman acquired 100,000 shares of the stock in a transaction that occurred on Tuesday, October 31st. The stock was purchased at an average cost of $28.24 per share, with a total value of $2,824,000.00. Following the completion of the acquisition, the director now owns 903,895 shares of the company’s stock, valued at $25,525,994.80. The disclosure for this purchase can be found here. 1.54% of the stock is owned by insiders.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.